Industrial choices for protein production by large-scale cell culture.
暂无分享,去创建一个
D K Robinson | L. Chu | D. Robinson | L Chu
[1] D. Lütkemeyer,et al. Development of Serum‐Free Bioreactor Production of Recombinant Human Thyroid Stimulating Hormone Receptor , 2000, Biotechnology progress.
[2] J Shiloach,et al. Production of HIV‐1 gp120 in Packed‐Bed Bioreactor Using the Vaccinia Virus/T7 Expression System , 2000, Biotechnology progress.
[3] F. Muzzio,et al. Computational and experimental investigation of flow and fluid mixing in the roller bottle bioreactor. , 2000, Biotechnology and bioengineering.
[4] B T Frohlich,et al. Measurement and Control of Dissolved Carbon Dioxide in Mammalian Cell Culture Processes Using an in Situ Fiber Optic Chemical Sensor , 2000, Biotechnology progress.
[5] S. Harvey,et al. Monitoring Adenovirus Infections with On‐Line and Off‐Line Methods , 2000, Biotechnology progress.
[6] M. Saedi,et al. Large-scale propagation of recombinant adherent cells that secrete a stable form of human glandular kallikrein, hK2. , 1999, Protein expression and purification.
[7] A J Sinskey,et al. Large‐scale Production of Mammalian Cells and Their Products: Engineering Principles and Barriers to Scale‐up , 1983, Annals of the New York Academy of Sciences.
[8] A Knoll,et al. First Steps in Robot Automation of Sampling and Sample Management during Cultivation of Mammalian Cells in Pilot Scale , 2000, Biotechnology progress.
[9] T. Ryll,et al. A Comparison of Different Methods To Determine the End of Exponential Growth in CHO Cell Cultures for Optimization of Scale‐Up , 2000, Biotechnology progress.
[10] Mark Lindsey,et al. Complexity among constituents of the HLA-B*1501 peptide motif , 1998, Immunogenetics.
[11] C. Hoy,et al. Multiple cell culture factors can affect the glycosylation of Asn-184 in CHO-produced tissue-type plasminogen activator. , 2000, Biotechnology and bioengineering.
[12] J. D. Yang,et al. Achievement of high cell density and high antibody productivity by a controlled-fed perfusion bioreactor process. , 2000, Biotechnology and bioengineering.
[13] J Tramper,et al. Shear sensitivity of animal cells from a culture-medium perspective. , 1998, Trends in biotechnology.
[14] C. Lamers,et al. Large-scale production of natural cytokines during activation and expansion of human T lymphocytes in hollow fiber bioreactor cultures. , 1999, Journal of immunotherapy.
[15] M. Perrier,et al. 293SF Metabolic Flux Analysis during Cell Growth and Infection with an Adenoviral Vector , 2000, Biotechnology progress.
[16] A. M. Moro,et al. Glucose uptake rate as a tool to estimate hybridoma growth in a packed bed bioreactor , 1999 .
[17] S. R. Nathan,et al. A systematic approach to the validation of process control parameters for monoclonal antibody production in fed-batch culture of a murine myeloma. , 2000, Biotechnology and bioengineering.
[18] Paul W. Sauer,et al. A high-yielding, generic fed-batch cell culture process for production of recombinant antibodies. , 2000, Biotechnology and bioengineering.
[19] M. Schenerman,et al. Comparability testing of a humanized monoclonal antibody (Synagis) to support cell line stability, process validation, and scale-up for manufacturing. , 1999, Biologicals : journal of the International Association of Biological Standardization.
[20] G. F. Wagner,et al. Expression, purification, and bioassay of human stanniocalcin from baculovirus-infected insect cells and recombinant CHO cells. , 1998, Protein expression and purification.